Response to dexamethasone was higher in cases with unmutated IGHV/high ZAP-70 expression, and the levels of induction the pro-apoptotic Bim protein correlated with the degree of cell death. GEP analysis showed few genes differentially expressed after dexamethasone treatment between mutated and unmutated cases. However, functional annotation analysis showed that unmutated cases had significant enrichment in terms related to apoptosis.
4 dexamethasone exposure, and that GILZ was more induced by dexamethasone treatment in these cases.
Conclusions
Unmutated IGHV/high ZAP-70 CLL cells exhibit better response to dexamethasone treatment, which is accompanied by a differential expression of genes involved in the glucocorticoid-receptor pathway and by an increased induction of genes related to apoptosis. Chemoimmunotherapy regimens like FCR (fludarabine, cyclophosphamide and rituximab) (1, 2) , FCR plus mitoxantrone (3, 4) , or FCR plus alemtuzumab(5) have proved to be highly effective in the treatment of this disease. Despite the excellent overall response and complete response rates obtained with these regimens, patients with 17p13.1 deletion and/or TP53 mutations usually exhibit a lower response rate, and shorter progression-free survival and overall survival (2, 6, 7) . There is no standard salvage treatment for patients with refractory disease, particularly those with TP53 abnormalities, and therapeutic options are based on non-genotoxic drugs like alemtuzuMab (8, 9) , flavopiridol(10-12), lenalidomide (13, 14) or glucocorticoids (15) (16) (17) , alone or in combination with monoclonal antibodies (5, (18) (19) (20) (21) . Patients that respond to these salvage treatments are recommended to undergo allogeneic stem-cell transplantation (22) .
The mechanisms by which glucocorticoids induce CLL cell death are still not well understood. Glucocorticoids bind to a multiprotein complex receptor present in the cytoplasm constituted by the receptor itself and several cochaperones (23) . After binding, the glucocorticoid-receptor dissociates from some of the cochaperone proteins and translocates into the nucleus, where it acts as a transcription factor modulating gene expression(24). Several studies have been conducted to identify genes that are regulated by glucocorticoids and have the ability to trigger lymphoid cell death, particularly in acute lymphoblastic
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Author Manuscript Published OnlineFirst on September 10, 2012; DOI: 10.1158/1078-0432.CCR- leukemia (25) (26) (27) (28) (29) (30) . In CLL, it has been found that dexamethasone up-regulates mRNA and protein expression of the pro-apoptotic BH3-only gene Bim(31). Of note, cell death induced by glucocorticoids is higher in CLL with unmutated IGHV genes (UCLL)/high ZAP-70 expression than in cases with mutated IGHV genes (MCLL)/low ZAP-70 (32) (33) (34) (35) , although the molecular mechanisms that could explain these differences have not been uncovered.
With this background, we aimed to widely analyze the modulation of gene expression induced by dexamethasone in CLL cells according to the different IGHV mutational status/ZAP-70 expression groups. For that, genome-wide gene expression profile (GEP) analysis was performed after dexamethasone treatment and genes of interest were retrieved for further study.
MATERIALS AND METHODS

Patient selection and sample collection
A group of 50 patients diagnosed with CLL was selected on the basis of the availability of frozen samples for biological studies. 
Ex-vivo treatment with dexamethasone and evaluation of the response
PBMCs from CLL patients were thawed at 37ºC and resuspended in standard culture medium (RPMI-1640 medium (Gibco, Paisley, Scotland, UK) supplemented with 10% heat-inactivated FBS (Gibco), 100 U/ml penicillin, 0.1 mg/ml streptomycin (Lonza, Viviers, Belgium), 2 mM L-glutamine and 1 mM sodium pyruvate (Gibco)) and cultured at 37ºC in a 5% CO 2 atmosphere at a density of 1 x 10 6 cells/ml. PBMCs were allowed to recover from the thawing process for one hour before manipulation. Samples were split in two for control 
ZAP-70 and IGHV mutational status analysis
Mutational status of the IGHV genes and ZAP-70 expression by flow cytometry were determined as previously described (37) . Patients with more than 98% germline identity for IGHV genes were considered to be unmutated. CLL cases were considered to have high ZAP-70 expression when ZAP-70 was ≥20%(37).
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Microarray analysis
Total RNA (2 µg) was converted into biotin-labeled cRNA and further fragmented and hybridized to oligonucleotide Affymetrix Human Genome U133 Plus 2.0 arrays (Affymetrix Inc, Santa Clara, CA). Expression measures were normalized and summarized using the frozen robust multiarray analysis (fRMA) methodology (38) . Clustering and heatmaps were performed with the TM4 Software Suite (39) . Gene expression data with log values lower than 5 were discarded. Differential expression analysis was carried out by a linear model using empirical Bayes method to moderate the standard errors of the estimated log-Ratio changes with the limma package (40) . The online tool David (41) was used for the functional annotation analysis using the BP_FAT category of Gene Ontology (GO). The GEP data has been deposited at the National Centre for Biotechnology Information's Gene Expression Omnibus (GEO ID: GSE33135). 
RNA interference experiments
Statistical analysis
Comparisons between groups were done using the Mann-Whitney test.
Correlations between measures were performed using a parametric linear regression model. For all comparisons, P-values were two-sided and the type I error was set at 5%. Statistical analyses were performed with the use of SPSS P=0.001). In absolute terms, the mean percentage of live cells after thawing in this series was 72% ± 14, whereas after 24 hours of culture the mean viability was 56% ± 15 for control cells and 44% ± 16 for treated cells.
Induction of Bim expression by dexamethasone correlates with the extent of apoptosis in CLL cells
The expression of the pro-apoptotic BH3-only gene Bim has been reported to be induced by dexamethasone at both mRNA and protein level in different cellular models, including CLL cells (26, 31, (42) (43) (44) . To study the kinetics of induction of Bim after treatment with dexamethasone, levels of Bim mRNA were analyzed by QRT-PCR at different time points in primary cells from 7 patients with CLL. As early as after 3 hours of treatment, an increase in Bim mRNA was already detected; in five of the cases, levels kept increasing up to 9 hours and then remained stable, whereas in the other two cases an additional increase in Bim levels was observed from 9 to 24 hours ( Figure 2A 
all down-regulated genes, a total of 132 probe sets were shared by both ZAP-70 groups. GO analysis of down-regulated probe sets showed that in both high and low ZAP-70 groups the most significant term was immune response. Of note, probe sets that were exclusively down-regulated in CLL cases with low ZAP-70 expression (n=90) were significantly enriched in genes related to regulation of apoptosis, being the majority of them involved in the positive regulation of this process.
The top 10 probe sets with the highest variation caused by the treatment with dexamethasone were subsequently selected (Table 1) group. Considering P-values lower than 0.001, 45 probe sets (38 genes) were identified as differentially regulated ( Figure 3B ). GO analysis revealed a significant enrichment in genes related to regulation of apoptosis. Among these 38 differentially regulated genes we observed that TSC22D3 (alias GILZ) clustered with the pro-apoptotic gene BCL2L11 (alias Bim) ( Figure 3B) indicating that the two genes were altered in a similar way by dexamethasone.
In addition, only in the high ZAP-70 group, GILZ was one of the most upregulated genes by dexamethasone (Table 1 ). These data suggested that GILZ may be implicated in the different response to dexamethasone observed in the ZAP-70 expression groups.
Increased levels of FKBP5 at baseline and after dexamethasone treatment correlate with enhanced apoptosis and high ZAP-70 expression
The GEP analysis revealed that FKBP5 was the most inducible gene by Figure 4C ). Of note, levels of FKBP5 reached after 6 hours of treatment were significantly higher in cases with high ZAP-70 expression (n=20) than in those with low ZAP-70 (n=23) (mean FKBP5 mRNAexpression ±SD: 4.31AU ±2.51 vs 1.95AU ±0.65; P<0.001; Figure 4D ).
GILZ expression highly correlates with the induction of apoptosis by dexamethasone in CLL
GILZ is a transcription regulator directly targeted by the glucocorticoid-receptor (45) which negatively controls important mediators of cell proliferation (46) . We found that GILZ was one of the top ten most inducible genes only in the high ZAP-70 group (Table 1) . Moreover, GILZ was one of the few genes differently regulated by dexamethasone in the two ZAP-70 subgroups ( Figure 3B ).
To further assess the relationship between GILZ expression, ZAP-70 expression and the response to dexamethasone, levels of GILZ mRNA were determined by QRT-PCR in 40 CLL samples with or without treatment with dexamethasone for 6 hours. In untreated samples, levels of GILZ were higher in the low ZAP-70 group (n=20) than in the high ZAP-70 group (n=20) (mean GILZ mRNA-expression ±SD: 40.45AU ±21.46 vs 32.71AU ±22.05; P=0.040; Figure   4E ). Conversely, and according to GEP results, induction of GILZ after Figure 4F ). Moreover, we observed that this induction of GILZ correlated with cell viability (n=40; P<0.001; Figure 4G ). Finally, and reinforcing that GILZ clustered with Bim in the GEP interaction term analysis, GILZ induction correlated with the increase of Bim expression (n=34; P=0.001; Figure 4H ) determined after 24 hours of treatment with dexamethasone.
Inhibition of FKBP5 or GILZ expression by siRNA in primary CLL cells impairs response to dexamethasone treatment ex vivo.
In order to investigate if FKBP5 and GILZ are directly participating in the apoptotic response to dexamethasone observed in primary CLL cells, we analyzed the response to this treatment ex vivo after 48h of transfection with siRNA targeting FKBP5 or GILZ in four CLL cases. As can be observed in 
DISCUSSION
Herein we report that the degree of apoptosis induced by dexamethasone in neoplastic B CLL lymphocytes ex-vivo is significantly higher in patients with UCLL/high ZAP-70 expression than in patients with MCLL/low ZAP-70 expression, which have a better prognosis. This is in agreement with what has been previously described using prednisone and methylprednisolone (32) (33) (34) (35) .
Interestingly, we showed that IGHV unmutated genes/high ZAP-70 expression conferred higher susceptibility to dexamethasone independently of the presence of 17p13.1 or 11q22.3 deletion. These results corroborated the clinical experience on the use of glucocorticoids in patients with high-risk cytogenetics (17, 19) .
Induction of expression of Bim protein has been shown to be implicated in apoptosis induced by dexamethasone in ALL (26, (42) (43) (44) and this protein appeared to be the unique pro-apoptotic protein involved in cell death induced by glucocorticoids in CLL(31). In our study, besides confirming the early upregulation of Bim expression on treatment with dexamethasone, we showed that dexamethasone-induced cell death positively correlated with levels of Bim induction. Altogether, these findings indicate that Bim is probably a downstream effector of dexamethasone in CLL. Since Bim pro-apoptotic mechanism has been demonstrated to be independent of p53 (47), its up-regulation could explain in part the response to glucocorticoids observed in some CLL cases with TP53 abnormalities (17, 19) .
GEP analysis revealed high similarities between ZAP-70 subgroups in terms of genes regulated after dexamethasone treatment, indicating that the different response to dexamethasone may not be due to an independent biological targeting of dexamethasone but to a differential capacity to induce cell death while inducing/repressing the same genes.
GEP results allowed us to select genes with significant levels of modulation along with biological relevance in the glucocorticoid pathway for further studies in larger series of patients. FKBP5, the cochaperone of the glucocorticoid- 
